High expression of long non-coding RNA ANRIL is associated with poor prognosis in hepatocellular carcinoma

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 3, 2015, Pages 3076-3082

  Hua, Long ^a   Wang, Chen Yu ^a   Yao, Kun Hou ^a   Chen, Jiang Tao ^a   Zhang, Jun Jie ^a   Ma, Wan Li ^a  

^a HENAN UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; IncRNA ANRIL; Invasion; Migration; Overall survival; Proliferation

Indexed keywords

ANRIL LONG NON-CODING RNA, HUMAN; LONG UNTRANSLATED RNA; SMALL INTERFERING RNA;

ADULT; AGED; BIOSYNTHESIS; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RNA, LONG NONCODING; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84933035314     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Shi J, Zhu L, Liu S and Xie WF. A meta-analysis of case-control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China. Br J Cancer 2005; 92: 607-612.
2. Gomaa AI, Khan SA, Toledano MB, Waked I and Taylor-Robinson SD. Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol 2008; 14: 4300-4308.
3. Bruix J and Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-1236.
4. Nagao T, Inoue S, Goto S, Mizuta T, Omori Y, Kawano N and Morioka Y. Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis. Ann Surg 1987; 205: 33-40.
5. Mattick JS and Makunin IV. Non-coding RNA. Hum Mol Genet 2006; 15 Spec No 1: R17-29.
6. Huttenhofer A, Schattner P and Polacek N. Non-coding RNAs: hope or hype? Trends Genet 2005; 21: 289-297.
7. Mercer TR, Dinger ME and Mattick JS. Long non-coding RNAs: insights into functions. Nature Reviews Genetics 2009; 10: 155-159.
8. Prensner JR and Chinnaiyan AM. The emergence of lncRNAs in cancer biology. Cancer Discov 2011; 1: 391-407.
9. Zhang H, Chen Z, Wang X, Huang Z, He Z and Chen Y. Long non-coding RNA: a new player in cancer. J Hematol Oncol 2013; 6: 37.
10. Yap KL, Li S, Munoz-Cabello AM, Raguz S, Zeng L, Mujtaba S, Gil J, Walsh MJ and Zhou MM. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell 2010; 38: 662-674.
11. Bochenek G, Hasler R, El Mokhtari NE, Konig IR, Loos BG, Jepsen S, Rosenstiel P, Schreiber S and Schaefer AS. The large non-coding RNA ANRIL, which is associated with atherosclerosis, periodontitis and several forms of cancer, regulates ADIPOR1, VAMP3 and C11ORF10. Hum Mol Genet 2013; 22: 4516-4527.
12. Zhang EB, Kong R, Yin DD, You LH, Sun M, Han L, Xu TP, Xia R, Yang JS, De W and Chen J. Long noncoding RNA ANRIL indicates a poor prognosis of gastric cancer and promotes tumor growth by epigenetically silencing of miR-99a/miR-449a. Oncotarget 2014; 5: 2276-2292.
13. Greene FL. The American Joint Committee on Cancer: updating the strategies in cancer staging. Bull Am Coll Surg 2002; 87: 13-15.
14. Kotake Y, Nakagawa T, Kitagawa K, Suzuki S, Liu N, Kitagawa M and Xiong Y. Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene 2011; 30: 1956-1962.
15. Bruix J and Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002; 35: 519-524.
16. Johnson PJ. Hepatocellular carcinoma: is current therapy really altering outcome? Gut 2002; 51: 459-462.
17. Endo H, Shiroki T, Nakagawa T, Yokoyama M, Tamai K, Yamanami H, Fujiya T, Sato I, Yamaguchi K, Tanaka N, Iijima K, Shimosegawa T, Sugamura K and Satoh K. Enhanced expression of long non-coding RNA HOTAIR is associated with the development of gastric cancer. PLoS One 2013; 8: e77070.
18. Zheng HT, Shi DB, Wang YW, Li XX, Xu Y, Tripathi P, Gu WL, Cai GX and Cai SJ. High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer. Int J Clin Exp Pathol 2014; 7: 3174-3181.
19. Shi X, Sun M, Liu H, Yao Y, Kong R, Chen F and Song Y. A critical role for the long non-coding RNA GAS5 in proliferation and apoptosis in non-small-cell lung cancer. Mol Carcinog 2013; [Epub ahead of print].
20. Ma MZ, Kong X, Weng MZ, Zhang MD, Qin YY, Gong W, Zhang WJ and Quan ZW. Long noncoding RNALET is a positive prognostic factor and exhibits tumor suppressive activity in gallbladder cancer. Mol Carcinog 2014; [Epub ahead of print].